Morgan Stanley’s cbdMD YCBD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $845 | Hold |
1,139
| – | – | ﹤0.01% | 7456 |
|
|
2025
Q4 | $1.54K | Hold |
1,139
| – | – | ﹤0.01% | 7292 |
|
|
2025
Q3 | $1.38K | Hold |
1,139
| – | – | ﹤0.01% | 7361 |
|
|
2025
Q2 | $1.02K | Buy |
1,139
+1,130
| +12,556% | +$1.48K | ﹤0.01% | 7334 |
|
|
2025
Q1 | $16 | Hold |
9
| – | – | ﹤0.01% | 7992 |
|
|
2024
Q4 | $26 | Hold |
9
| – | – | ﹤0.01% | 7811 |
|
|
2024
Q3 | $32 | Hold |
9
| – | – | ﹤0.01% | 7724 |
|
|
2024
Q2 | $44 | Hold |
9
| – | – | ﹤0.01% | 7541 |
|
|
2024
Q1 | $69 | Sell |
9
-10
| -53% | -$62 | ﹤0.01% | 7421 |
|
|
2023
Q4 | $156 | Buy |
19
+10
| +111% | +$63 | ﹤0.01% | 7381 |
|
|
2023
Q3 | $77 | Hold |
9
| – | – | ﹤0.01% | 7463 |
|
|
2023
Q2 | $104 | Hold |
9
| – | – | ﹤0.01% | 7492 |
|
|
2023
Q1 | $634 | Hold |
9
| – | – | ﹤0.01% | 7408 |
|
|
2022
Q4 | $738 | Sell |
9
-1
| -10% | -$101 | ﹤0.01% | 7516 |
|
|
2022
Q3 | $1K | Sell |
10
-3
| -23% | -$431 | ﹤0.01% | 7617 |
|
|
2022
Q2 | $2K | Sell |
13
-15
| -54% | -$3.55K | ﹤0.01% | 7612 |
|
|
2022
Q1 | $11K | Sell |
28
-3
| -10% | -$1.01K | ﹤0.01% | 7386 |
|
|
2021
Q4 | $12K | Sell |
31
-77
| -71% | -$44.8K | ﹤0.01% | 7419 |
|
|
2021
Q3 | $80K | Sell |
108
-84
| -44% | -$70.3K | ﹤0.01% | 6491 |
|
|
2021
Q2 | $201K | Sell |
192
-183
| -49% | -$219K | ﹤0.01% | 6014 |
|
|
2021
Q1 | $559K | Buy |
375
+362
| +2,785% | +$526K | ﹤0.01% | 5094 |
|
|
2020
Q4 | $14K | Sell |
13
-42
| -76% | -$38.2K | ﹤0.01% | 6551 |
|
|
2020
Q3 | $40K | Buy |
55
+20
| +57% | +$19.1K | ﹤0.01% | 5804 |
|
|
2020
Q2 | $24K | Buy |
35
+20
| +133% | +$8.97K | ﹤0.01% | 5966 |
|
|
2020
Q1 | $5K | Sell |
15
-41
| -73% | -$16.2K | ﹤0.01% | 6230 |
|
|
2019
Q4 | $45K | Buy |
56
+35
| +167% | +$42K | ﹤0.01% | 5890 |
|
|
2019
Q3 | $29K | Buy |
21
+10
| +91% | +$16K | ﹤0.01% | 5904 |
|
|
2019
Q2 | $24K | Buy |
11
+3
| +38% | +$6.09K | ﹤0.01% | 5876 |
|
|
2019
Q1 | $12K | Buy |
8
+5
| +167% | +$7.86K | ﹤0.01% | 6142 |
|
|
2018
Q4 | $3K | Buy |
+3
| New | +$4.27K | ﹤0.01% | 6382 |
|
|
2018
Q3 | – | Sell |
-30
| Closed | -$38K | – | 6822 |
|
|
2018
Q2 | $39K | Buy |
+30
| New | +$49.3K | ﹤0.01% | 5979 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6711 |
|
Other funds holding YCBD
WVP
CL
XT
CD
AA
VCM
VFT
CPIG
Morgan Stanley's YCBD Position: Q1 2026 in Review
Morgan Stanley held its cbdMD (YCBD) position steady in Q1 2026 at 1,139 shares worth $845. The position accounts for ﹤0.01% of the portfolio, ranked #7456.
Morgan Stanley first reported a position in YCBD in Q2 2018 and has held it in 31 quarters since. The position peaked at $559K in Q1 2021. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.
- Morgan Stanley held 1,139 shares of cbdMD worth $845 as of Q1 2026.
- Morgan Stanley left its cbdMD share count unchanged in Q1 2026.
- cbdMD made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7456 holding.
- Morgan Stanley first reported a position in cbdMD in Q2 2018 and has held it in 31 quarters since.
- Morgan Stanley's cbdMD position peaked at $559K in Q1 2021.
- 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.